PULMONARY ALVEOLAR MICROLITHIASIS (SLC34A2) GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited     
The Pulmonary Alveolar Microlithiasis (SLC34A2) Gene Panel by NGS detects mutations in the SLC34A2 gene associated with rare lung disorders characterized by calcium phosphate deposits in the alveoli. Metropolis Healthcare uses advanced next-generation sequencing technology to provide accurate identification of genetic variants. This test is valuable for patients with unexplained respiratory symptoms, restrictive lung patterns, or a family history of pulmonary alveolar microlithiasis. Early genetic diagnosis supports clinical management, monitoring, and genetic counseling for affected families 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA Blood

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What does the Pulmonary Alveolar Microlithiasis Gene Panel detect?
It identifies mutations in the SLC34A2 gene linked to pulmonary alveolar microlithiasis.

Who should take this test?
Patients with unexplained lung symptoms, restrictive pulmonary function, or a family history of the condition.

What sample is required?
EDTA blood is used for next-generation sequencing analysis.

How does Metropolis Healthcare perform this test?
Metropolis employs high-precision NGS technology to detect both common and rare genetic variants.

Can this test guide clinical management?
Yes, results help clinicians plan monitoring, treatment, and follow-up strategies.

Is genetic counseling recommended?
Yes, the test provides important information for family planning and inheritance risk assessment.

How long are results available from Metropolis Healthcare?
Reports are typically available within a few weeks depending on the analysis complexity.

Why is early detection important?
It enables timely intervention, appropriate monitoring, and informed decision-making for patients and families

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab